Neomics has found a very promising target, AIMP2/AIMP2-DX2 for siRNA therapy application to tumoric lung cancer cells and we intend to focus the remaining resources on developing through clinical trials, the siRNA therapy as a first priority More
Aerosolized immunogenic compositions that may prove useful for vaccination against respiratory infections and may provide a platform for generating mucosal antibody responses against other pathogens. More
Researchers at the School of Pharmacy, University of London, have developed a novel method for formulation of drugs for efficient delivery to the lung using pressurized metered dose inhalers (pMDIs). More